These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 2621453)
1. Preliminary evidence that azidothymidine does not affect hepatitis B virus replication in acquired immunodeficiency syndrome (AIDS) patients. Farraye FA; Mamish DM; Zeldis JB J Med Virol; 1989 Dec; 29(4):266-7. PubMed ID: 2621453 [TBL] [Abstract][Full Text] [Related]
2. Absent inhibition of hepatitis B virus replication by azidothymidine in patients chronically coinfected by HIV-1 and HBV. Gallian P; De Lamballerie X; Lehucher MP; Dhiver C; Ravaux I New Microbiol; 1996 Apr; 19(2):167-9. PubMed ID: 8722313 [TBL] [Abstract][Full Text] [Related]
3. No effect of zidovudine on hepatitis B virus replication in homosexual men with symptomatic HIV-1 infection. Gilson RJ; Hawkins AE; Kelly GK; Gill SK; Weller IV AIDS; 1991 Feb; 5(2):217-20. PubMed ID: 2031694 [TBL] [Abstract][Full Text] [Related]
4. Effect of 3'-azido-3'-deoxythymidine on replication of duck hepatitis B virus in vivo and in vitro. Haritani H; Uchida T; Okuda Y; Shikata T J Med Virol; 1989 Dec; 29(4):244-8. PubMed ID: 2559951 [TBL] [Abstract][Full Text] [Related]
5. Zidovudine. Powderly WG Mo Med; 1989 Nov; 86(11):741-3. PubMed ID: 2682195 [TBL] [Abstract][Full Text] [Related]
7. In vitro inhibition of hepatitis B virus replication by 2',3'-dideoxyguanosine, 2',3'-dideoxyinosine, and 3'-azido-2',3'-dideoxythymidine in 2.2.15 (PR) cells. Aoki-Sei S; O'Brien MC; Ford H; Fujii H; Gilbert DA; Cooney DA; Johns DG; Broder S; Mitsuya H J Infect Dis; 1991 Nov; 164(5):843-51. PubMed ID: 1940465 [TBL] [Abstract][Full Text] [Related]
8. Effects of lamivudine on replication of hepatitis B virus in HIV-infected men. Benhamou Y; Katlama C; Lunel F; Coutellier A; Dohin E; Hamm N; Tubiana R; Herson S; Poynard T; Opolon P Ann Intern Med; 1996 Nov; 125(9):705-12. PubMed ID: 8929003 [TBL] [Abstract][Full Text] [Related]
9. Biological comparison of wild-type and zidovudine-resistant isolates of human immunodeficiency virus type 1 from the same subjects: susceptibility and resistance to other drugs. Rooke R; Parniak MA; Tremblay M; Soudeyns H; Li XG; Gao Q; Yao XJ; Wainberg MA Antimicrob Agents Chemother; 1991 May; 35(5):988-91. PubMed ID: 1649576 [TBL] [Abstract][Full Text] [Related]
10. Viral dynamics in vivo: limitations on estimates of intracellular delay and virus decay. Herz AV; Bonhoeffer S; Anderson RM; May RM; Nowak MA Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7247-51. PubMed ID: 8692977 [TBL] [Abstract][Full Text] [Related]
11. [Prospects in the treatment of AIDS. II. AZT and related compounds; practical conclusions]. Grieb P Pol Arch Med Wewn; 1992; 87(4-5):316-23. PubMed ID: 1381825 [No Abstract] [Full Text] [Related]
12. Failure of azidothymidine to inhibit human immunodeficiency virus (HIV) replication in a promonocytic cell line (U937). Uherová P; Schmidtmayerová H; Mayer V Acta Virol; 1991 Aug; 35(4):357-64. PubMed ID: 1724875 [TBL] [Abstract][Full Text] [Related]
13. Synergistic inhibition of human immunodeficiency virus type 1 replication by 5-ethyl-1-ethoxymethyl-6-(phenylthio)uracil (E-EPU) and azidothymidine in vitro. Baba M; Ito M; Shigeta S; Tanaka H; Miyasaka T; Ubasawa M; Umezu K; Walker RT; De Clercq E Antimicrob Agents Chemother; 1991 Jul; 35(7):1430-3. PubMed ID: 1929304 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of 3'azido-3'deoxythymidine-resistant HIV-1 infection by dehydroepiandrosterone in vitro. Yang JY; Schwartz A; Henderson EE Biochem Biophys Res Commun; 1994 Jun; 201(3):1424-32. PubMed ID: 8024587 [TBL] [Abstract][Full Text] [Related]
15. Use of evolutionary limitations of HIV-1 multidrug resistance to optimize therapy. Chow YK; Hirsch MS; Merrill DP; Bechtel LJ; Eron JJ; Kaplan JC; D'Aquila RT Nature; 1993 Feb; 361(6413):650-4. PubMed ID: 7679778 [TBL] [Abstract][Full Text] [Related]
16. Zidovudine inhibits hepatitis B virus replication. Berk L; Schalm SW; Heijtink RA Antiviral Res; 1992 Aug; 19(2):111-8. PubMed ID: 1444323 [TBL] [Abstract][Full Text] [Related]
17. Enhanced oral absorption and antiviral activity of 1-O-octadecyl-sn-glycero-3-phospho-acyclovir and related compounds in hepatitis B virus infection, in vitro. Hostetler KY; Beadle JR; Kini GD; Gardner MF; Wright KN; Wu TH; Korba BA Biochem Pharmacol; 1997 Jun; 53(12):1815-22. PubMed ID: 9256156 [TBL] [Abstract][Full Text] [Related]
18. Effect of 3'-azido-3'-deoxythymidine on human immunodeficiency virus type 1 replication in human fetal brain macrophages. Geleziunas R; Arts EJ; Boulerice F; Goldman H; Wainberg MA Antimicrob Agents Chemother; 1993 Jun; 37(6):1305-12. PubMed ID: 8392310 [TBL] [Abstract][Full Text] [Related]
19. Hydroxyurea as an inhibitor of human immunodeficiency virus-type 1 replication. Lori F; Malykh A; Cara A; Sun D; Weinstein JN; Lisziewicz J; Gallo RC Science; 1994 Nov; 266(5186):801-5. PubMed ID: 7973634 [TBL] [Abstract][Full Text] [Related]
20. Cytotoxicity of 3'-azido-3'-deoxythymidine correlates with 3'-azidothymidine-5'-monophosphate (AZTMP) levels, whereas anti-human immunodeficiency virus (HIV) activity correlates with 3'-azidothymidine-5'-triphosphate (AZTTP) levels in cultured CEM T-lymphoblastoid cells. Törnevik Y; Ullman B; Balzarini J; Wahren B; Eriksson S Biochem Pharmacol; 1995 Mar; 49(6):829-37. PubMed ID: 7702641 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]